[1]
I. A. Goldina and E. V. Markova, “An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1”, Патогенез, vol. 20, no. 3, pp. 81-82, Oct. 2022.